Press Releases

At its tenth anniversary, the Renewable Fuel Standard's requirement to substitute biofuels for fossil fuels has displaced nearly 1.9 billion barrels of foreign oil and reduced associated carbon emissions by 589.3 million metric tons.

BIO issued a statement regarding the United States Patent and Trademark Office’s (PTO) proposed changes to the rules governing the Patent Trial and Appeal Board (PTAB) inter partes review (IPR) proceedings...

BIO Investor Forum to be held October 20-21 in San Francisco, California


BIO announced the appointment of Jeanne Haggerty as Senior Vice President of Federal Government Relations.

BIO expresses thanks to Representatives Bill Pascrell (D-N.J.), Mike Fitzpatrick (R-PA), and Richard Neal (D-MA) for introducing, H.R. 3390, which provides renewable chemical producers access to production or investment tax credits currently available to other renewable energy producers.

Today BIO joined a coalition of organizations urging the Government of Japan to maintain the established reimbursement pricing structure for pharmaceuticals and medical devices.

BIO’s comments make clear that if the agency does not correct its course on the program, it will continue to undermine the goals and requirements of the statute, undercut investment in advanced and cellulosic biofuels, and raise greenhouse gas emissions in the transportation fuel sector.

Washington, D.C. (July 23, 2015) – In bipartisan action today in the U.S. House of Representatives, the Safe and Accurate Food Labeling Act (H.R. 1599) was passed by a vote of 275 to 150.  The bill provides a national, consumer-friendly approach to the labeling of foods made with or without genetically modified organisms (GMOs).    

BIO thanked Senate Finance Committee Chairman Orrin Hatch (R-Utah), Ranking Member Ron Wyden (D-Ore.) and other committee members for marking up legislation to extend critical tax incentives. The legislation would extend for two years the important Research & Development Tax Credit, the Second Generation Biofuel Producer Tax Credit, the Special Depreciation Allowance for Second Generation Biofuel Plant Property, and the Controlled Foreign Corporation Look-Through Rule. 

This year’s Conference drew around 1,200 industry leaders from 725 companies, 50 countries and 37 states, as well as the District of Columbia. Organized by the Biotechnology Industry Organization (BIO), the World Congress on Industrial Biotechnology hosted more than 1,400 partnering meetings, a 40% increase from the 2014 BIO World Congress.

BIO President and CEO Jim Greenwood was invited to make a presentation and participate in today’s national stakeholder forum, hosted by the U.S. Department of Agriculture, to announce the new Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program (“Section 9003 Program”).

Dr. Jennifer Holmgren, Chief Executive Officer of the innovative carbon recycling company LanzaTech, will deliver remarks and will be presented the inaugural Rosalind Franklin Award by BIO at the 2015 World Congress on Industrial Biotechnology in Montréal.

BIO applauds bipartisan action today by the U.S. House Agriculture Committee to advance the Safe and Accurate Food Labeling Act (H.R. 1599).

The George Washington Carver Award Will Be Presented at the 12th Annual BIO World Congress on Industrial Biotechnology; Winner to Provide Remarks

Biotechnology companies LanzaTech and Renmatix today received awards in the Presidential Green Chemistry Challenge for industrial biotechnology applications that produce carbon negative renewable chemicals and fuels. BIO congratulates its member companies on receiving the awards, which recognize industrial biotechnology’s contribution to reducing pollution at the source.

We praise the House of Representatives for today’s vote to pass 21st Century Cures legislation that recognizes the critical link between research, development and reimbursement to expedite the delivery of breakthrough treatments and cures to patients suffering from life-threatening and debilitating diseases.  

American farmers continue to value the economic, environmental and societal benefits of genetically engineered (GE) crops – especially GE soybeans, cotton and corn – according to newly released data from the U.S. Department of Agriculture (USDA).

BIO issued the following statement regarding an amendment to the 21st Century Cures Initiative legislation filed by Rep. Dave Brat (R-VA) that would convert the mandatory funding for the National Institutes of Health (NIH) to discretionary spending. 

BIO is pleased to announce the schedule of workshops for the 2015 World Congress on Industrial Biotechnology. These workshops are designed for focused discussions on the newest trends in business strategies, investment opportunities and technology development in industrial biotechnology.

Regulation System Must Encourage – not Hinder – Innovation

Washington, D.C. (July 2, 2015) – The Biotechnology Industry Organization (BIO) welcomes the release of a White House memo regarding the regulation of biotechnology-derived products.

We stand united in our continued opposition to H.R. 9, the Innovation Act, as it is currently drafted.

America's renewable chemical and biobased manufacturing industry generated 4 million jobs and contributed $369 billion to the U.S. economy in 2013 alone, according to a recently issued USDA report. The Biotechnology Industry Organization (BIO) is pleased to announce that breakout sessions at the 2015 World Congress on Industrial Biotechnology will feature experts and executives who will showcase the latest innovations, remark on the future of renewable chemicals, and the biobased industry, and highlight how companies and innovators are working to shift towards a bioeconomy. This year’s BIO World Congress on Industrial Biotechnology will be held July 19-22, 2015 at the Palais des congrès de Montréal in Montréal, Canada

The Biotechnology Industry Organization (BIO) today applauded the U.S. Department of Agriculture’s release of new interim final rules for the Biorefinery, Renewable Chemical, and Biobased Product Manufacturing Assistance Program (“9003 Program”).

Governor Greg Abbott for signed critical legislation to create a pathway for the substitution of interchangeable biologic medicines.